Orchestra BioMed Holdings, Inc. (OBIO)
Nasdaq: OBIO · Surgical & Medical Instruments & Apparatus · New Hope, PA · filing with the SEC since 2020
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 12, 2026 | Mar 31, 2025 | Mar 27, 2024 | Jan 25, 2023 | Mar 31, 2022 | Mar 10, 2021 |
| Revenue | 33,482,000 | 2,638,000 | 2,760,000 | 3,533,000 | · | · |
| For lenders | ||||||
| Net interest income | · | · | 3,849,000 | 50,000 | · | · |
| Cost of revenue | 190,000 | 204,000 | 186,000 | 211,000 | · | · |
| Research and development | 58,185,000 | 42,804,000 | 33,822,000 | 21,945,000 | · | · |
| Selling, general and administrative | 26,914,000 | 23,931,000 | 20,258,000 | 14,034,000 | · | · |
| General and administrative | · | · | · | 2,960,264 | 274,756 | · |
| Total costs and expenses | 85,289,000 | 66,939,000 | 54,266,000 | 36,190,000 | · | · |
| Operating income | -51,807,000 | -64,301,000 | -51,506,000 | -32,657,000r | -394,756 | · |
| Interest expense | · | 297,000 | 1,400,000 | 1,300,000 | · | · |
| Interest and investment income | · | · | · | 345,141 | 16,003 | · |
| Interest income (expense), net | -1,148,000 | 3,356,000 | 3,849,000 | · | · | · |
| Other income (expense), net | · | -11,000 | · | · | · | · |
| Income tax expense | 0 | · | · | · | · | · |
| Net income including non-controlling interests | -52,701,000 | -61,024,000 | -49,120,000 | -33,608,000 | -378,753 | · |
| Net income | -52,701,000 | -61,024,000 | -49,120,000 | -33,608,000r | -378,753 | · |
| Net income to common shareholders | -52,955,000 | -61,024,000 | · | · | · | · |
| Earnings per share, basic | -1.11 | -1.66 | -1.48 | -2.24r | -0.02 | · |
| Earnings per share, diluted | -1.11 | -1.66 | -1.48 | -2.24r | -0.02 | · |
| Earnings per share, basic and diluted | · | · | · | · | -0.02 | · |
| Weighted average shares, basic | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584r | 20,450,000 | · |
| Weighted average shares, diluted | 47,747,078 | 36,821,042 | 33,225,227 | 14,988,584r | 20,450,000 | · |
| Weighted average shares, basic and diluted | · | · | · | · | 20,450,000 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseDebtInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted